The investment seeks to achieve long-term growth of capital and income by investing primarily in a diversified portfolio of equity securities of larger, well-established companies... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CGFCX | 70.02 | 0.44 | +0.63% |
American Funds Growth Fund of Amer 529C | |||
EUGDX | 30.00 | N/A | N/A |
Morgan Stanley Europe Opportunity I | |||
JSCOX | 22.24 | N/A | N/A |
Janus Henderson Small Cap Value I | |||
JFNCX | 55.47 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
VALSX | 36.81 | -0.29 | -0.78% |
Value Line Select Growth Fund |
A.I.dvisor indicates that over the last year, MDDAX has been loosely correlated with FFFMX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if MDDAX jumps, then FFFMX could also see price increases.
Ticker / NAME | Correlation To MDDAX | 1D Price Change % | ||
---|---|---|---|---|
MDDAX | 100% | N/A | ||
FFFMX - MDDAX | 61% Loosely correlated | +0.18% | ||
FFMMX - MDDAX | 60% Loosely correlated | +0.17% | ||
VIVAX - MDDAX | 54% Loosely correlated | N/A | ||
VIVIX - MDDAX | 54% Loosely correlated | N/A | ||
VVIAX - MDDAX | 54% Loosely correlated | N/A | ||
More |